Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2012 Jul;46(6):437-9.
doi: 10.1097/MCG.0b013e3182549528.

Lessons from pharmacogenetics and metoclopramide: toward the right dose of the right drug for the right patient

Michael Camilleri, Andrea Shin
Editorial

Lessons from pharmacogenetics and metoclopramide: toward the right dose of the right drug for the right patient

Michael Camilleri et al. J Clin Gastroenterol. 2012 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest.

Comment on

References

    1. Parkman HP, Misra A, Jacobs M, et al. Clinical response and side effects of metociopramide: associations with clinical, demographic, and pharmacogenetic parameters. J Clin Gastroenterol. [this issue] - PubMed
    1. Tonini M, Cipollina L, Poluzzi E, Crema F, Corazza GR, De Ponti F. Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics. Aliment Pharmacol Ther. 2004;19:379–390. - PubMed
    1. Evans WE, Relling MV. Pharmacogenomics: translating functional genomics into rational therapeutics. Science. 1999;286:487–491. - PubMed
    1. Rao AS, Camilleri M. Review article: metoclopramide and tardive dyskinesia. Aliment Pharmacol Ther. 2010;31:11–19. - PubMed
    1. Abell TL, Bernstein RK, Cutts T, et al. Treatment of gastroparesis: a multidisciplinary clinical review. Neurogastroenterol Motil. 2006;18:263–283. - PubMed